Top compounds associated with response to LINC00238


Feature Type Standardized
Nominal ANOVA
mRNA BRD-A05715709 CTRPv2 pan-cancer AAC -0.11 0.06
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.07
mRNA paclitaxel UHNBreast pan-cancer AAC -0.54 0.07
mRNA Bortezomib gCSI pan-cancer AAC 0.11 0.07
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC -0.14 0.07
mRNA YM-155 CTRPv2 pan-cancer AAC -0.07 0.07
mRNA BRD-K07442505 CTRPv2 pan-cancer AAC -0.068 0.07
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC -0.14 0.07
mRNA 5-FU CTRPv2 pan-cancer AAC 0.062 0.08
Download CSV